AcquisitionOther
AgeX Therapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
AgeX Therapeutics, Inc. -> target · $10,000,000
Serina has developed a proprietary drug delivery polymer technology based upon the polymer poly (2-oxazoline), or POZ™, and is developing a pipeline of proprietary and partnered programs applying this platform to Parkinson’s disease, cannabinoids, cancer, and
Open source record (SEC) ↗